Dear Editor, Brazil is one of the few countries with warm humid tropical weather, offering conducive environment to the nourishment of tropical pathogens [1, 2]. Following the footprints of dengue [1] and Zika virus [2], yellow fever has recently emerged as the new public health menace. The responsible agent of the infection is an RNA virus of genus Flavivirus known as yellow fever virus. Prominent symptoms comprise fever, loss of appetite, fatigue, nausea, and in severe cases, bleeding and jaundice. Since December 2016, Brazil is confronted with a new wave of yellow fever outbreak [3]. The reckoned affectees include 586 confirmed cases along with 190 confirmed deaths (Table I) [4] (as of April 5, 2017). Furthermore, 450 incidence cases and 49 suspected deaths are under investigation, making the ongoing outbreak as the deadliest in the history of Brazil. In addition, 1,324 epizootic deaths in primates have been reported to Ministry of Health, Brazil [5]. By now, human yellow fever cases have originated in multiple states including Minas Gerais, Espirito Santo, Rio de Janeiro, and Sao Paulo. All cases reported till date have been associated with jungle mosquitoes Haemagogus and Sabethes [5]. With the preexisting burden of Zika virus [2] and dengue [1], yellow fever outbreak is another setback for country's health and economic sector. The immunization pace has been amplified and a total of 18.8 million doses of yellow fever vaccine have